alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**
**Exhibit 31.4**

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF**

**THE SECURITIES EXCHANGE ACT OF 1934,**

**AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, KeithCummings, certify that: 

 
2.
I have reviewed this Annual Report on Form 10-K of Pliant Therapeutics,Inc.; and 

 
3.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. 

 
Date: March 1, 2022  By: 
/s/ Keith Cummings
   Keith Cummings, M.D., M.B.A.   Chief Financial Officer   (Principal Financial Officer)**
<PAGE>
                                                                    EXHIBIT 12.1

                         SECURITY CAPITAL PACIFIC TRUST                     
               COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                         (Dollar amounts in thousands)

                                  (Unaudited)


<TABLE>
<CAPTION>
                                       Six  months ended
                                            June 30,                                Twelve Months Ended December 31,
                                            --------                   -----------------------------------------------------------
                                      1997            1996               1996         1995        1994         1993          1992
                                      ----            ----               ----         ----        ----         ----          ----

<S>                                  <C>            <C>                <C>         <C>         <C>           <C>           <C>
Earnings from operations...........  $43,341        $47,382            $ 94,089    $ 81,696     $46,719      $23,191       $ 9,037
Add:
     Interest Expense..............   29,759         13,777              35,288      19,584      19,442        3,923         3,214
                                     -------        -------            --------    --------     -------      -------       -------
Earnings as adjusted...............  $73,100        $61,159            $129,377    $101,280     $66,161      $27,114       $12,251
                                     =======        =======            ========    ========     =======      =======       =======
Fixed charges:
     Interest expense..............  $29,759        $13,777            $ 35,288    $ 19,584     $19,442      $ 3,923       $ 3,214
     Capitalized interest..........    8,751          7,509              16,941      11,741       6,029        2,818           989
                                     -------        -------            --------    --------     -------      -------       -------
     Total fixed charges...........  $38,510        $21,286            $ 52,229    $ 31,325     $25,471      $ 6,741       $ 4,203
                                     =======        =======            ========    ========     =======      =======       =======
Ratio of earnings to fixed
 charges...........................      1.9            2.9                 2.5         3.2         2.6          4.0           2.9
                                     =======        =======            ========    ========    ========      =======       =======
</TABLE>
<PAGE>
 
                                                                EXHIBIT 10.3(c)

[LETTERHEAD OF PLAYBOY ENTERPISES, INC. APPEARS HERE]      

  DATE      October 11, 1996
      --------------------------------------------------------------------------

  TO        Herb Laney
    ----------------------------------------------------------------------------

  FROM      Christie Hefner
      --------------------------------------------------------------------------

  SUBJECT:  Employment Terms
          ----------------------------------------------------------------------

--------------------------------------------------------------------------------
     This memo restates and supersedes our prior letter to you of February 26,
     1993 and my memo to you of this year dated May 1, 1996, both of which are
     terminated as of the date hereof.

     Effective with the fiscal year commencing July 1, 1996, you will carry the
     title of Senior Vice President and President, Catalog Group. Your salary
     will continue to be $275,000 per year.

     The terms of, and your entitlement to compensation under, your special
     incentive compensation plan for the fiscal years ending June 1, 1997, 1998
     and 1999 will be governed exclusively by the 1996 Playboy Enterprises, Inc.
     Incentive Compensation Plan for Herbert M. Laney (the "Plan"), a copy of
     which has been provided to you. You understand and agree that your
     entitlement to such compensation with respect to such periods is subject
     to, and contingent upon, approval by the Company's stockholders of the Plan
     at the Company's annual meeting of stockholders scheduled to be held
     November 13, 1996, and any and all rights thereunder shall be void and of
     no force and effect should the Company's stockholders not approve the Plan.

     If your employment is terminated for any reason other than cause, you will 
     receive a full year's severance.

     Herb, I am very pleased to memorialize the terms of your arrangement with
     the Company. You continue to exhibit exceptional performance, innovation
     and enthusiasm for the catalog business. We have great expectations for
     growth in this group for the next several years.

          ACCEPTED AND AGREED TO:


          /s/ Herb Laney
          -----------------------
          Herb Laney

          Date  October 14, 1996
              -------------------
Exhibit 10.481


 


ASSIGNMENT


 


This Assignment is made as of the 28th
day of December, 2004 by INLAND REAL ESTATE
ACQUISITIONS, INC., an Illinois corporation (“Assignor”) to and for
the benefit of INLAND WESTERN PHENIX CITY,
L.L.C., a Delaware limited liability company (“Assignee”).


 


Assignor does hereby sell, assign, transfer, set over and convey unto
Assignee all of its right, title and interest as Buyer under into that certain
Real Estate Sale Agreement for the purchase and sale of a Shopping Center dated
as of November 15, 2004, as amended and entered into by Regency Realty
Group, Inc., a Florida corporation, as Seller, and Assignor, as Buyer
(collectively,  the “Agreement”), for the
sale and purchase of the property described by the Agreement, located in Phenix
City, Alabama.


 


Assignor represents and warrants that it is the Buyer under the
Agreement, and that it has not sold, assigned, transferred, or encumbered such
interest in any way to any other person or entity. By acceptance hereof,
Assignee accepts the foregoing assignment and agrees, from and after the date
hereof, to (i) perform all of the obligations of Buyer under the Agreement, and
(ii) indemnify, defend, protect and hold Assignor harmless from and against all
claims and liabilities arising under the Agreement.


 


IN WITNESS WHEREOF, Assignor and Assignee have executed this instrument
as of the date first written above.


 


 


	
   

  	
  ASSIGNOR:

  
	
   

  	
   

  
	
   

  	
  INLAND REAL ESTATE
  ACQUISITIONS, INC.

  an Illinois corporation

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Jason A. Lazarus

  	
   

  
	
   

  	
  Name:

  	
  Jason A. Lazarus

  	
   

  
	
   

  	
  As Its:

  	
  V.P.

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  ASSIGNEE:

  
	
   

  	
   

  
	
   

  	
  INLAND WESTERN PHENIX
  CITY, L.L.C.,

  a Delaware limited liability company

  
	
   

  	
   

  
	
   

  	
  By: Inland Western Retail
  Real Estate Trust, Inc.,

  a Maryland corporation, its sole member

  
	
   

  	
   

  
	
   

  	
  By:

  	
  [ILLEGIBLE]

  	
   

  
	
   

  	
  Name:

  	
  [ILLEGIBLE]

  	
   

  
	
   

  	
  As Its:

  	
  [ILLEGIBLE]
215 La. 310

#### SMITH v. ATKINS.

No. 39295.

Supreme Court of Louisiana.

April 25, 1949.

Hussey •& Smi-t-h, of Shreveport, -for defendant and appellant.

Robert J. N-ew-so-n, of Shreveport, for plain-tiff and appellee.

PONDER, Justice.

The plaintiff, -appellee, moves to dismiss the appeal in this -c-ase on the -ground that the transcript is incomplete.

. An appeal will -not he dismissed without first allowing the appellant time to complete -the -transcript -in -compliance with th-e provisions of Act 234 of 1932.

Upon submission of the motion to dismiss the appeal, the appellant has filed a supplemental transcript containing -the documents -that the -ap-pell-ee claims were left out of the transcript. On three prior occasions we ha-v-e entertained controversies -between the parties to -this -suit involving the -property in dispute herein. See Atkins v. Smith, 204 La. 468, 15 So.2d 855; Atkins v. Smith, 207 La. 560, 21 So.2d 728 and Smith v. Atkins, 211 La. 369, 30 So.2d 121. It w-as not necessary -to incorporate in the transcript a co-py -of -our opinions in those -cases or portions of ou-r records -in th-e prior -suits -because we can take -cognizance of -our -own -records.

For the reasons assigned, the motion is denied.

O’NIELL, C. J., takes no -part.
UNITED STATES DISTRICT COURT 

DISTRICT OF NEW HAMPSHIRE

Patrick O’Leary

v. 05-cv-335-SM

Dartmouth College Trustees

ORDER

Re: Document No. 5, Motion to Dismiss:

Ruling: Defendant’s motion to dismiss plaintiff’s disparate

impact age discrimination claim is granted, for the reasons given

in defendant’s motion and reply. However, plaintiff may engage in

appropriate discovery, and will be allowed to amend his complaint

to add a disparate impact claim if he determines in good faith that

the facts warrant such a claim. As is apparent from plaintiff’s

pleadings, he candidly concedes that he cannot currently allege

facts sufficient to adequately plead a disparate impact claim.

Steven J. McAuliffe

Chief District Judge

Date: June 19, 2006

cc: K. William Clauson, Esq.

Edward A. Haffer, Esq. 

Case 1:05-cv-00335-SM Document 17 Filed 06/19/06 Page 1 of 1
<PAGE>

                                                                   EXHIBIT 10.32

   Summary of Key Terms of Additional Compensation Between AMIS Holdings, Inc.
   and Christine King

Name:             Christine King

Title:            President and Chief Executive Officer

Base Salary:      Increased to $500,000 in 2004

Bonus Plan:       Eligible for participation in the company's Key Manager
                  Incentive Program and Sales Incentive Plan with a target
                  payout at 100% of base salary and a maximum payout of 150% of
                  base salary
<PAGE>
                                NIELS W. JOHNSEN
                              CONSULTING AGREEMENT

     This will confirm that International Shipholding Corporation has agreed to
retain you as a consultant commencing January 1, 2005 through December 31, 2005,
for a fee of $125,000, payable in 12 monthly installments of $10,416.67, plus
reasonable out-of-pocket expenses. At the end of the period, this Agreement is
automatically extended on a month-by-month basis. Either party on a 90-day
notice may cancel this Agreement. Please sign below to acknowledge your
agreement to this consulting arrangement.

                                        Sincerely,


                                        /s/ E. F. Johnsen
                                        ----------------------------------------
                                        E. F. Johnsen
                                        Chairman of the Board


AGREED AND ACCEPTED:


/s/ N. W. Johnsen
-------------------------------------
N. W. Johnsen

Date : 12/21/04
UNITED STATES DISTRICT COURT FOR THE

DISTRICT OF NEW HAMPSHIRE

United States of America

v. Case No. 05-cr-74-01-SM

Mark Landers

O R D E R

Defendant Landers’ motion to continue the final pretrial conference and

trial is granted (document 11). Trial has been rescheduled for the March 2006

trial period. Defendant Landers shall file a waiver of speedy trial rights not

later than October 21, 2005. On the filing of such waiver, his continuance shall

be effective. 

The Court finds that the ends of justice served by granting a continuance

outweigh the best interest of the public and the defendant in a speedy trial, 18

U.S.C. § 3161(h)(8)(B)(iv), in that failure to grant a continuance would

unreasonably deny defendant the reasonable time necessary for effective

preparation taking into account the exercise of due diligence under the

circumstances. 

Final Pretrial Conference: February 22, 2006 at 2:00 p.m.

Jury Selection: March 7, 2006 at 9:30 a.m.

Case 1:05-cr-00074-SM Document 12 Filed 10/18/05 Page 1 of 2
2

SO ORDERED.

____________________________

Steven J. McAuliffe

 Chief Judge

October 18, 2005

cc: Jonathan Saxe, Esq.

Alfred Rubega, AUSA

US Probation

US Marshal

Case 1:05-cr-00074-SM Document 12 Filed 10/18/05 Page 2 of 2
<PAGE>

EXHIBIT 32


             LIFESTYLE INNOVATIONS, INC FORM 10-QSB FOR THE QUARTER
                            ENDED DECEMBER 31, 2004
               CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF
             ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul Johnson, certify that

         1.       I am the Acting Chief Executive Officer and principal
                  accounting officer of Lifestyle Innovations, Inc.
         2.       Attached to this certification is Form 10-QSB for the quarter
                  ended December 31, 2004, a periodic report (the "periodic
                  report") filed by the issuer with the Securities Exchange
                  Commission pursuant to Section 13(a) or 15(d) of the
                  Securities and Exchange Act of 1934 (the "Exchange Act"),
                  which contains condensed consolidated financial statements.
         3        I hereby certify, pursuant to 18 U.S.C. Section 1350, as
                  adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
                  2002, that
                  o        The periodic report containing the condensed
                           consolidated financial statements fully complies with
                           the requirements of Section 13(a) or 15(d) of the
                           Exchange Act, and
                  o        The information in the periodic report fairly
                           presents, in all material respects, the consolidated
                           financial condition and results of operations of the
                           issuer for the periods presented.

February 10, 2005                                       /s/ Paul Johnson
                                                        -----------------------
                                                        Paul Johnson
                                                        President, Acting CEO
                                                        (and equivalent of CFO)


A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by Lifestyle Innovations, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

This certification will not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, or otherwise subject to the liability of that
section. This certification will not be deemed to be incorporated by reference
into any filing under the Securities Act of 1933 or the Securities Exchange Act
of 1934 even if the document with which it is submitted to the Securities and
Exchange Commission is so incorporated by reference.


                                       30
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, DC 20549








FORM 8-K








CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934








Date of Report (date of earliest event reported):  September 17, 2013





Frontier Communications Corporation


(Exact name of registrant as specified in its charter)





Delaware


(State or other jurisdiction of incorporation)





001-11001
06-0619596(Commission File Number)
(IRS Employer Identification No.)3 High Ridge Park, Stamford, Connecticut
06905(Address of principal executive offices)
(Zip Code)





(203) 614-5600


(Registrant’s telephone number, including area code)





_________________


(Former name or former address, if changed since last report)





Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):





o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)





o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))





o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 8.01
Other Events




The information set forth in the press release issued by Frontier Communications Corporation on September 17, 2013, attached hereto as Exhibit 99.1, is incorporated herein by reference.




Item 9.01
Financial Statements and Exhibits




(d)           Exhibits




99.1
Press Release of Frontier Communications Corporation released on September 17, 2013.












SIGNATURES







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.










FRONTIER COMMUNICATIONS CORPORATIONDate:  September 18, 2013
By:/s/ Susana D’EmicSusana D’EmicSenior Vice President andController
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> UT
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               DEC-31-1996
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                      173,929
<OTHER-PROPERTY-AND-INVEST>                          0
<TOTAL-CURRENT-ASSETS>                          79,497
<TOTAL-DEFERRED-CHARGES>                        13,293
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                                 266,719
<COMMON>                                         1,244
<CAPITAL-SURPLUS-PAID-IN>                       37,687
<RETAINED-EARNINGS>                             39,033
<TOTAL-COMMON-STOCKHOLDERS-EQ>                  77,964
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      8,000
<LONG-TERM-DEBT-NET>                            70,752
<SHORT-TERM-NOTES>                              38,000
<LONG-TERM-NOTES-PAYABLE>                       71,200
<COMMERCIAL-PAPER-OBLIGATIONS>                       0
<LONG-TERM-DEBT-CURRENT-PORT>                    1,600
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                      1,581
<LEASES-CURRENT>                                   429
<OTHER-ITEMS-CAPITAL-AND-LIAB>                  69,974
<TOT-CAPITALIZATION-AND-LIAB>                  266,719
<GROSS-OPERATING-REVENUE>                       61,673
<INCOME-TAX-EXPENSE>                             2,302
<OTHER-OPERATING-EXPENSES>                      11,004
<TOTAL-OPERATING-EXPENSES>                      19,784
<OPERATING-INCOME-LOSS>                          6,216
<OTHER-INCOME-NET>                                  72
<INCOME-BEFORE-INTEREST-EXPEN>                   6,288
<TOTAL-INTEREST-EXPENSE>                         1,830
<NET-INCOME>                                     4,458
<PREFERRED-STOCK-DIVIDENDS>                        174
<EARNINGS-AVAILABLE-FOR-COMM>                    4,284
<COMMON-STOCK-DIVIDENDS>                         1,194
<TOTAL-INTEREST-ON-BONDS>                        1,520
<CASH-FLOW-OPERATIONS>                         (7,053)
<EPS-PRIMARY>                                     3.44
<EPS-DILUTED>                                     3.44
        

</TABLE>
IIA 

107TH CONGRESS 

2D SESSION H. J. RES. 112

IN THE SENATE OF THE UNITED STATES 

OCTOBER 3, 2002

Received 

JOINT RESOLUTION 

Making further continuing appropriations for the fiscal year 

2003, and for other purposes.

1 Resolved by the Senate and House of Representatives 

2 of the United States of America in Congress assembled, 

3 That Public Law 107–229 is amended by striking the date
2

HJ 112 RDS 

1 specified in section 107(c) and inserting in lieu thereof 

2 ‘‘October 11, 2002’’.

Passed the House of Representatives October 3, 

2002. 

Attest: JEFF TRANDAHL, 

Clerk.
<PAGE>

                                                                  Exhibit 10.4.2

                         [Merck & Co., Inc. Letterhead]

October 24, 1996

Mr. Murray Goldberg
Regeneron Pharmaceutical, Inc.
777 Old Saw Mill River road
Tarrytown, NY  10591

Dear Mr. Goldberg:

This shall serve as a memorandum of our agreement to amend Schedule A of the
Manufacturing Agreement between Merck & Co., Inc. ("Merck") and Regeneron
Pharmaceuticals, Inc. (Regeneron") dated September 18, 1995, so as to permit
Merck to use Room [***], as depicted on the diagram annexed to Schedule A of the
Manufacturing Agreement, in conjunction with Regeneron, for [***] purposes
in support of the manufacture of Product pursuant to said agreement. Room [***]
is indicated in red outline on the diagram attached hereto. Regeneron shall
designate said area as a "[***] area" on the diagram attached to Schedule A of
the Agreement.

In consideration for the [***] use of Room [***] for the term of the Agreement,
Merck, within 60 days of the execution of this letter agreement by Regeneron ,
shall remit to Regeneron a one-time payment of [***].

If the foregoing is agreeable, would you please so indicate by signing, dating
and returning to us the enclosed copy of this letter.

                                                 Very truly yours,

                                                 Merck & Co., Inc.

                                                 /s/John M. Pashko
                                                 -------------------------------
                                                 John M. Pashko
                                                 Date: 11/25/96

The foregoing is agreed to:

Regeneron  Pharmaceuticals, Inc.

/s/Murray Goldberg
------------------
Murray Goldberg
Date: 11/06/96